Intraoperative intravital microscopy permits the study of human tumour vessels

Nature Communications

Volumn 7, Issue , 2016, Pages

  Fisher, Daniel T ^a   Muhitch, Jason B ^a   Kim, Minhyung ^a   Doyen, Kurt C ^b   Bogner, Paul N ^a   Evans, Sharon S ^a   Skitzki, Joseph J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Spectra Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

BLOOD; DISEASE TREATMENT; DRUG; HISTOPATHOLOGY; IMMUNOASSAY; MICROSCOPY; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; ERYTHROCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVITAL MICROSCOPY; MELANOMA; MOUSE; NONHUMAN; OXYGENATION; SHEAR STRESS; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR TUMOR; VEIN DIAMETER; ANIMAL; BLOOD VESSEL; CHEMISTRY; EVALUATION STUDY; MICROCIRCULATION; PATHOPHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; CELL LINE, TUMOR; HUMANS; INTRAVITAL MICROSCOPY; MELANOMA; MICE; MICROCIRCULATION;

EID: 84958568210     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10684     Document Type: Article

References (50)

1. Jain, R. K., Munn, L. L., Fukumura, D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2, 266-276 (2002).
2. Fukumura, D., Duda, D. G., Munn, L. L., Jain, R. K. Tumor microvasculature and microenvironment: novel insights through intravital imaging in preclinical models. Microcirculation 17, 206-225 (2010).
3. Barretto, R. P. et al. Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy. Nat. Med. 17, 223-228 (2011).
4. McDonald, D. M., Choyke, P. L. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 9, 713-725 (2003).
5. Helmlinger, G., Yuan, F., Dellian, M., Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182 (1997).
6. Dewhirst, M. W. et al. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br. J. Cancer 79, 1717-1722 (1999).
7. Zijlstra, A., Lewis, J., Degryse, B., Stuhlmann, H., Quigley, J. P. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13, 221-234 (2008).
8. Beerling, E., Ritsma, L., Vrisekoop, N., Derksen, P. W., van Rheenen, J. Intravital microscopy: new insights into metastasis of tumors. J. Cell Sci. 124, 299-310 (2011).
9. Mikucki, M. E. et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat. Commun. 6, 7458 (2015).
10. Wu, N. Z., Klitzman, B., Dodge, R., Dewhirst, M. W. Diminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265-4268 (1992).
11. Sumen, C., Mempel, T. R., Mazo, I. B., von Andrian, U. H. Intravital microscopy: visualizing immunity in context. Immunity 21, 315-329 (2004).
12. Fisher, D. T. et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J. Clin. Invest. 121, 3846-3859 (2011).
13. Ellenbroek, S. I., van Rheenen, J. Imaging hallmarks of cancer in living mice. Nat. Rev. Cancer 14, 406-418 (2014).
14. Pittet, M. J., Weissleder, R. Intravital imaging. Cell 147, 983-991 (2011).
15. Palmer, G. M. et al. In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters. Nat. Protoc. 6, 1355-1366 (2011).
16. Turley, R. S. et al. Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for intransit melanoma. Clin. Cancer Res. 18, 3328-3339 (2012).
17. Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782-795 (2013).
18. Algire, G. An adaptation of the transparent-chamber technique to the mouse. J. Natl Cancer Inst. 4, 1-11 (1943).
19. Grigorova, I. L. et al. Cortical sinus probing, S1P1-dependent entry and flowbased capture of egressing T cells. Nat. Immunol. 10, 58-65 (2009).
20. Moussion, C., Girard, J. P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479, 542-546 (2011).
21. von Andrian, U. H. Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 3, 287-300 (1996).
22. Chen, Q. et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat. Immunol. 7, 1299-1308 (2006).
23. Alford, R. et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol. Imaging 8, 341-354 (2009).
24. Sturm, M. B. et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci. Transl. Med. 5, 184ra161 (2013).
25. Moore, G. E. et al. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J. Neurosurg. 5, 392-398 (1948).
26. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat. Med. 17, 1315-1319 (2011).
27. Kalogeromitros, D. C. et al. Allergy skin testing in predicting adverse reactions to fluorescein: a prospective clinical study. Acta Ophthalmol. 89, 480-483 (2011).
28. Dellinger, R. P. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36, 296-327 (2008).
29. Chang, Y. S. et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl Acad. Sci. USA 97, 14608-14613 (2000).
30. Stylianopoulos, T., Jain, R. K. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc. Natl Acad. Sci. USA 110, 18632-18637 (2013).
31. Secomb, T. W. et al. Microangiectasias: structural regulators of lymphocyte transmigration. Proc. Natl Acad. Sci. USA 100, 7231-7234 (2003).
32. Lawrence, M. B., Kansas, G. S., Kunkel, E. J., Ley, K. Threshold levels of fluid shear promote leukocyte adhesion through selectins (CD62L,P,E). J. Cell Biol. 136, 717-727 (1997).
33. Melder, R. J., Munn, L. L., Yamada, S., Ohkubo, C., Jain, R. K. Selectin-and integrin-mediated T-lymphocyte rolling and arrest on TNF-alpha-activated endothelium: augmentation by erythrocytes. Biophys. J. 69, 2131-2138 (1995).
34. Schwinn, D. A., McIntyre, R. W., Reves, J. G. Isoflurane-induced vasodilation: role of the alpha-adrenergic nervous system. Anesth. Analg. 71, 451-459 (1990).
35. Hoeben, A. et al. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580 (2004).
36. Tozer, G. M. et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer. Res. 61, 6413-6422 (2001).
37. Ntziachristos, V. Going deeper than microscopy: the optical imaging frontier in biology. Nat. Methods 7, 603-614 (2010).
38. Nagy, J. A., Chang, S. H., Shih, S. C., Dvorak, A. M., Dvorak, H. F. Heterogeneity of the tumor vasculature. Semin. Thromb. Hemost. 36, 321-331 (2010).
39. Less, J. R., Skalak, T. C., Sevick, E. M., Jain, R. K. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51, 265-273 (1991).
40. Sennino, B. et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov. 2, 270-287 (2012).
41. Sorensen, A. G. et al. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 72, 402-407 (2012).
42. Emblem, K. E. et al. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat. Med. 19, 1178-1183 (2013).
43. Folberg, R. et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100, 1389-1398 (1993).
44. Makitie, T., Summanen, P., Tarkkanen, A., Kivela, T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J. Natl Cancer Inst. 91, 359-367 (1999).
45. Quester, R., Schroder, R. The shrinkage of the human brain stem during formalin fixation and embedding in paraffin. J. Neurosci. Methods 75, 81-89 (1997).
46. McLaughlin, R. A. et al. Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer. Cancer Res. 70, 2579-2584 (2010).
47. Konerding, M. A., Fait, E., Gaumann, A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br. J. Cancer 84, 1354-1362 (2001).
48. Himburg, H. A. et al. Spatial comparison between wall shear stress measures and porcine arterial endothelial permeability. Am. J. Physiol. Heart. Circ. Physiol. 286, H1916-H1922 (2004).
49. Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., Tannock, I. F. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clin. Cancer Res. 11, 8782-8788 (2005).
50. Weidner, N. Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol. 444, 305-323 (2008).